KZR - Kezar Life Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5195.79M
Enterprise Value 319.52M
Trailing P/E N/A
Forward P/E 1-2.44
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.14
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.60

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-75.15%
S&P500 52-Week Change 321.38%
52 Week High 322.50
52 Week Low 32.36
50-Day Moving Average 33.67
200-Day Moving Average 33.48

Share Statistics

Avg Vol (3 month) 3236.62k
Avg Vol (10 day) 3693.43k
Shares Outstanding 538.17M
Float 11.37M
% Held by Insiders 112.04%
% Held by Institutions 124.17%
Shares Short (Jan 30, 2020) 4921.66k
Short Ratio (Jan 30, 2020) 44.35
Short % of Float (Jan 30, 2020) 47.33%
Short % of Shares Outstanding (Jan 30, 2020) 44.80%
Shares Short (prior month Dec 30, 2019) 4835.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.38%
Return on Equity (ttm)-31.19%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -32.61M
Net Income Avi to Common (ttm)-31.29M
Diluted EPS (ttm)-1.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)85.24M
Total Cash Per Share (mrq)4.45
Total Debt (mrq)6.57M
Total Debt/Equity (mrq)7.59
Current Ratio (mrq)16.67
Book Value Per Share (mrq)4.52

Cash Flow Statement

Operating Cash Flow (ttm)-28.14M
Levered Free Cash Flow (ttm)-17.23M